Analysis of dideoxyadenosine triphosphate by CE with fluorescence detection. I. Derivatization through the phosphate group

Electrophoresis

Volumn 28, Issue 21, 2007, Pages 3948-3956

  Mallampati, Swapna ^a   Van Aerschot, Arthur ^b   Hoogmartens, Jos ^a   Van Schepdael, Ann ^a  

^a DEPARTMENT OF PHARMACEUTICAL AND PHARMACOLOGICAL SCIENCES   (Belgium)

^b REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

2 ,3 Dideoxyadenosine 5 triphosphate; CE; Didanosine; Fluorescence detection; Human immunodeficiency virus

Indexed keywords

CHEMICAL REACTIONS; VIRUSES;

1-METHYLIMIDAZOLE; 2′,3′-DIDEOXYADENOSINE-5′-TRIPHOSPHATE; CE; DERIVATIZATIONS; DIDANOSINE; ETHYLENE DIAMINE; FLUORESCENCE DETECTION; HUMAN IMMUNODEFICIENCY VIRUS; TRIPHOSPHATE; UV DETECTION;

FLUORESCENCE;

1 (3 DIMETHYLAMINOPROPYL) 3 ETHYLCARBODIIMIDE; 1 METHYLIMIDAZOLE; 2',3' DIDEOXYADENOSINE 5 TRIPHOSPHATE; 2',3' DIDEOXYADENOSINE TRIPHOSPHATE; 4,4 DIFLUORO 5,7 DIMETHYL 4 BORA 3A,4A DIAZA S INDACENE 3 PROPIONYL ETHYLENEDIAMINE; ADENOSINE TRIPHOSPHATE; BUFFER; DANSYL ETHYLENEDIAMINE; DEOXYADENOSINE 5 TRIPHOSPHATE; DEOXYADENOSINE TRIPHOSPHATE; DIDANOSINE; DRUG METABOLITE; ETHYLENEDIAMINE DERIVATIVE; NUCLEOTIDE; PHOSPHATE; REAGENT; UNCLASSIFIED DRUG;

ARTICLE; CAPILLARY ZONE ELECTROPHORESIS; CHEMICAL MODIFICATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DERIVATIZATION; DRUG STRUCTURE; FLUORESCENCE ANALYSIS; FLUORESCENCE SPECTROSCOPY; MICELLAR ELECTROKINETIC CHROMATOGRAPHY; PROCESS OPTIMIZATION; SENSITIVITY AND SPECIFICITY; SEPARATION TECHNIQUE; ULTRAVIOLET SPECTROPHOTOMETRY;

EID: 36348953859     PISSN: 01730835     EISSN: 15222683     Source Type: Journal    
DOI: 10.1002/elps.200700234     Document Type: Article

References (20)

1. Cahours, X., Dessans, H., Morin, P., Dreux, M., Agrofoglio, L., J. Chromatogr. A 2000, 895, 101-109.
2. Perry, C. M., Noble, S., Drugs 1999, 58, 1099-1135.
3. Becher, F., Landman, R., Mboup, S., Kane, C. N. T. et al., AIDS 2004, 18, 181-187.
4. Quirk, E., McLeod, H., Powderly, W., Clin. Infect. Dis. 2004, 39, 98-106.
5. Stein, D. S., Moore, K. H. P., Pharmacotherapy 2001, 21, 11-34.
6. Becher, F., Pruvost, A., Gale, J., Couerbe, P. et al., J. Mass Spectrom. 2003, 36, 879-890.
7. Le Saint, C., Terreux, R., Duval, D., Durant, J. et al., Antimicrob. Agents Chemother. 2004, 48, 589-595.
8. Cahours, X., Tran, T. T., Mesplet, N., Kileda, C. et al., J. Pharm. Biomed. Anal. 2001, 26, 819-827.
9. Becher, F., Pruvost, A., Goujard, C., Guerreiro, C. et al., Rapid Commun. Mass Spectrom. 2002, 16, 555-565.
10. Bezy, V., Chaimbault, P., Morin, P., Unger, S. E. et al., Electrophoresis 2006, 27, 2464-2476.
11. Ludwig, J., Acta Biochim. Biophys. Hung. 1981, 16, 131-133.
12. Khan, K., Van Schepdael, A., Saison-Behmoaras, T., Van Aerschot, A., Hoogmartens, J., Electrophoresis 1998, 19, 2163-2168.
13. European Pharmacopoeia, European Directorate for the Quality of Medicines of the Council of Europe, Strasbourg, France 2005.
14. Wirtz, M., Stach, D., Kliem, H. C., Wiessler, M., Schmitz, O. J., Electrophoresis 2004, 25, 839-845.
15. Lyko, F., Stach, D., Brenner, A., Stilgenbauer, S. et al., Electrophoresis 2004, 25, 1530-1535.
16. Cornelius, M., Worth, C. G. C., Kliem, H. C., Wiessler, M., Schmeiser, H. H., Electrophoresis 2005, 26, 2591-2598.
17. Sonoki, S., Kadoike, Y., Kiyokawa, M., Hisamatsu, S., J. Liq. Chromatogr. 1993, 76, 2731-2739.
18. Sonoki, S., Sanda, A., Hisamatsu, S., J. Liq. Chromatogr. 1994, 17, 1057-1064.
19. Mallampati, S., Leonard, S., De Vulder, S., Hoogmartens, J., Van Schepdael, A., Electrophoresis 2005, 26, 4079-4088.
20. Linares, R. M., Ayala, J. H., Afonso, A. M., Gonzalez, V., Analyst 1998, 123, 725-729.